Member
BC3 Technologies Inc
Founded in 2018 in Baltimore, BC3 Technologies is a minority-owned enterprise dedicated to revolutionizing emergency medical response. The company focuses on addressing critical gaps in emergency medical care, particularly in the management of life-threatening arterial bleeding, through innovative hemostatic solutions. BC3 Technologies aims to save lives by providing efficient, effective, and accessible products for medical, military, and general consumer sectors.
Industries
N/A
Nr. of Employees
small (1-50)
BC3 Technologies Inc
3701-A Southwestern Blvd, Baltimore MD, 21229
Patents
Products
Aerosolized hemostatic wound spray
An aerosol-formulated chitosan-based wound spray designed to form a barrier and promote rapid hemostasis when applied to severe bleeding wounds.
Aerosolized hemostatic wound spray
An aerosol-formulated chitosan-based wound spray designed to form a barrier and promote rapid hemostasis when applied to severe bleeding wounds.
Expertise Areas
- Aerosolized hemostatic product development
- Hemostatic formulation chemistry (chitosan-based)
- Medical device regulatory strategy and 510(k) submissions
- Preclinical and comparative efficacy testing
Key Technologies
- Aerosol delivery systems for topical therapeutics
- Chitosan-based hemostatic formulations
- Micron-scale particle engineering
- Timed-dose aerosol canister design